2021
DOI: 10.1007/s13193-021-01327-3
|View full text |Cite
|
Sign up to set email alerts
|

Adenosquamous Carcinoma of Ampulla of Vater—a Rare Entity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…The multivariate analysis showed that age, ethnicity, adenosquamous histology, differentiation grade, and lymphovascular invasion were independent prognostic factors for OS (Murimwa et al, 2021). ASCs of the ampulla of Vater have also been described in the literature, confirming its more aggressive behavior, with a worse prognosis than ampullary adenocarcinomas mainly due to the increased frequency of lymphovascular invasion and distant metastases (Maji et al, 2021).…”
Section: Adenosquamous Carcinoma Of Gallbladdermentioning
confidence: 83%
“…The multivariate analysis showed that age, ethnicity, adenosquamous histology, differentiation grade, and lymphovascular invasion were independent prognostic factors for OS (Murimwa et al, 2021). ASCs of the ampulla of Vater have also been described in the literature, confirming its more aggressive behavior, with a worse prognosis than ampullary adenocarcinomas mainly due to the increased frequency of lymphovascular invasion and distant metastases (Maji et al, 2021).…”
Section: Adenosquamous Carcinoma Of Gallbladdermentioning
confidence: 83%
“…The incidence of duodenal carcinoma has recently increased due to the widespread use and development of endoscopic examination [ 1 , 2 ]. Although most duodenal carcinomas are adenocarcinomas, a small number of cases have been reported of adenosquamous carcinoma (ASC), characterized by variable combinations of two malignant components: adenocarcinoma and squamous cell carcinoma [ 3 , 4 ]. Non-ampullary duodenal adenosquamous carcinoma (NADASC) is rare.…”
Section: Introductionmentioning
confidence: 99%